729 filings
Page 17 of 37
DEFA14A
CBAY
Cymabay Therapeutics Inc
11 May 20
Additional proxy soliciting materials
5:15pm
10-Q
2020 Q1
CBAY
Cymabay Therapeutics Inc
Quarterly report
11 May 20
4:08pm
DEFA14A
CBAY
Cymabay Therapeutics Inc
11 May 20
Additional proxy soliciting materials
4:05pm
8-K
CBAY
Cymabay Therapeutics Inc
11 May 20
CymaBay Reports First Quarter 2020 Financial Results and Provides Corporate Update
4:02pm
PRER14A
CBAY
Cymabay Therapeutics Inc
5 May 20
Preliminary revised proxy
4:25pm
CORRESP
CBAY
Cymabay Therapeutics Inc
5 May 20
Correspondence with SEC
12:00am
PRRN14A
Engine Capital, L.P.
1 May 20
Revised preliminary proxy statement filed by non-management
2:50pm
UPLOAD
CBAY
Cymabay Therapeutics Inc
30 Apr 20
Letter from SEC
12:00am
UPLOAD
CBAY
Cymabay Therapeutics Inc
29 Apr 20
Letter from SEC
12:00am
10-K/A
2019 FY
CBAY
Cymabay Therapeutics Inc
Annual report (amended)
29 Apr 20
12:00am
PREC14A
CBAY
Cymabay Therapeutics Inc
27 Apr 20
Preliminary proxy with contested solicitation
4:42pm
PREC14A
CBAY
Cymabay Therapeutics Inc
24 Apr 20
Preliminary proxy with contested solicitation
4:50pm
PRE 14A
CBAY
Cymabay Therapeutics Inc
21 Apr 20
Preliminary proxy
5:00pm
10-K
2019 FY
CBAY
Cymabay Therapeutics Inc
Annual report
16 Mar 20
4:42pm
DEFA14A
CBAY
Cymabay Therapeutics Inc
13 Mar 20
Additional proxy soliciting materials
5:29pm
SC 13D/A
CBAY
Cymabay Therapeutics Inc
13 Mar 20
CymaBay Therapeutics / ENGINE CAPITAL ownership change
5:12pm
8-K
CBAY
Cymabay Therapeutics Inc
12 Mar 20
CymaBay Reports Fourth Quarter and Fiscal Year End 2019 Financial Results and Provides Corporate Update
4:06pm
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 20
CymaBay Therapeutics, Inc.
5:02pm
SC 13G/A
Perceptive Advisors LLC
14 Feb 20
CymaBay Therapeutics, Inc.
4:26pm
SC 13G/A
CBAY
Cymabay Therapeutics Inc
14 Feb 20
Beneficial ownership report (amended)
4:07pm